Pearl Diagnostics

Baltimore, MD · Founded 2014 · Privately Held (backing)

Developer of in vitro diagnostic tests designed to aid diagnosis and screening for bacterial and fungal lung infections. Pearl Diagnostics is based in Baltimore, MD and was founded in 2014. Its last reported valuation was $15 million in Jun 2022. It has raised $4.5 million across 2 recorded rounds; the latest was an $11.2 million early-stage round in Mar 2026.

Last reported valuation
$15.0M
Oct 2026
Priced at
—
Total raised
$4.5M
Last round
Early Stage VC
Mar 2026
What is Pearl Diagnostics worth?
$15.0Mlast reported valuation · Oct 2026

Pearl Diagnostics's last reported valuation, Jun 2022. Nothing priced has surfaced since.

Free account
More of Pearl Diagnostics with a free account
  • ·The complete investor list: 11 names
  • ·Watch Pearl Diagnostics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Pearl Diagnostics funding history

2 rounds
DateRoundRaisedPost-money
Mar 2026Early Stage VC$11.2M▮
Feb 2022Seed Round$3.5M▮
Unlock post-money valuations

Membership and data by Private Market View

Pearl Diagnostics valuation

Pearl Diagnostics's last reported valuation was $15 million in Jun 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has Pearl Diagnostics raised?

Pearl Diagnostics has raised $4.5 million across 2 recorded rounds since 2022. The largest was a $3.5 million seed round in Feb 2022; the most recent was an $11.2 million early-stage round in Mar 2026.

Pearl Diagnostics has filed 2 Form Ds with the SEC since 2022, most recently in Apr 2026 ($11.2 million sold to 21 investors).

How Pearl Diagnostics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Pearl Diagnostics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Pearl Diagnostics

What is Pearl Diagnostics worth?
Pearl Diagnostics is valued at $15.0M as of Oct 2026. Pearl Diagnostics's last reported valuation, Jun 2022. Nothing priced has surfaced since.
How much has Pearl Diagnostics raised?
Pearl Diagnostics has raised $4.5M in total funding across 2 recorded rounds.
When did Pearl Diagnostics last raise?
Pearl Diagnostics last raised in Mar 2026 (Early Stage VC), raising $11.2M.